Swiss pharmaceutical giant Novartis made history as the first company to win FDA approval for a CAR-T therapy in the United States. Novartis announced that its genetically modified autologous (“self-derived”) immunocellular therapy, Kymriah, will cost $475,000 per treatment course. Shortly thereafter, Kite Pharma announced the approval of its CAR-T therapy, Yescarta, in the U.S. with a list price of $373,000. While these prices are expensive, they are far from trendsetting.

Cell Therapy Pricing and Products

In this article:

• Cell Therapy Cost
• Pricing of Approved Cell Therapy Products
• Wound Care Therapy
• Cartilage Based Cell Therapy
• Intravenous Cell Therapy
• Cell-Based Gene Therapy
• Cost of Stem Cell Therapy
• Autologous vs. Allogeneic Stem Cell Transplants
• Cell Therapy Pricing

[Read more…]

Regenerative medicine is a fascinating topic, because it requires you to ask yourself: Would you want to live to be 200 years old? A scientist from Stanford University thinks that it’s possible – so much so that he has placed a bet that there is someone alive today who will live to be 200 years old.

Over recent decades, modern scientific developments have led to a dramatic increase in human lifespan. But how much further can we go? Does regenerative medicine have the power to enable us all to live for many more years?

Let’s dive into this fascinating topic and find out more about regenerative medicine. How could it extend human life into the future? [Read more…]